AzTrials
AzTrials

Pre-Frail Older AdultsPE(PP)NCT05963113

Pharyngeal Exercise (Plus Protein)

A study testing Pharyngeal Swallowing Exercises, Protein Supplementation and MRI in people with Pre-Frail Older Adults, run by NYU Langone Health at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The swallowing muscles are prone to decreased strength and function as part of the natural aging process which can lead to difficulty swallowing, malnutrition, and frailty. Exercise and nutrition are powerful stimulators of muscular change. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Pre-Frail Older Adults
What is being tested?
Pharyngeal Swallowing Exercises, Protein Supplementation and MRI
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
2 sitesUnited States
Study dates
22 May 2024to 31 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Participants must be 65 years of age or older.
  • Participants must score a 1 or 2 on the FRAIL scale OR a 4 or greater on the Strength, Assistance in Walking, Rise from a Chair, Climb Stairs and Falls (SARC-F) Questionnaire.
  • Participants must score 26 or greater on the Montreal Cognitive Assessment (MoCA).
  • Willingness to participate in the study procedures.

Who cannot join

  • Known structural or neurological causes of dysphagia.
  • Cannot consume high levels of protein (Chronic Kidney Disease Stage 3 or higher).
  • Contraindications to 3T whole body MRI scanners (e.g., pacemaker, cerebral aneurysm clip, cochlear implant, presence of shrapnel in strategic locations, metal in the eye, claustrophobia, or other problems).

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Sonja Molfenter contact

212-992-7694

Smm16@nyu.edu

Maria Travino Sampler contact

Maria.TrivinoSamper@nyulangone.org

United States2 sites, 2 recruiting
  • NYU Steinhardt School of Education

    New York, New York, 10003

    Recruiting
  • NYU Langone Health

    New York, New York, 10017

    Recruiting

Other trials in United States

About this study

Official title: A Single-center Randomized Clinical Trial to Test the Efficacy of Pharyngeal Swallowing Exercises (With or Without Protein Supplementation) to Build Pharyngeal Muscular Reserve in Pre-frail Older Adults

The swallowing muscles are prone to decreased strength and function as part of the natural aging process which can lead to difficulty swallowing, malnutrition, and frailty. Exercise and nutrition are powerful stimulators of muscular change. The proposed research will investigate the effectiveness of a 12-week proactive regimen of swallowing exercises (with or without daily protein supplement drinks) to improve the composition, force, and physiology of the swallowing muscles and explore the relationship to overall health and physical function in 80 community-dwelling older adults. Each participant will serve as their own control for 12 weeks before being randomized to complete swallowing exercises alone or swallowing exercises with protein drinks.

Being tested
Pharyngeal Swallowing Exercises, Protein Supplementation, MRI
Keywords
proactive exercise, protein, nutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pharyngeal Swallowing ExercisesBehavioural

    12-weeks of proactive pharyngeal swallowing exercises conducted 5 times per week. The exercise program will include the following four exercises: effortful saliva swallows, tongue-hold swallows, effortful pitch glides and posterior lingual resistance. Each exercise set will include 10 repetitions of each exercise (40 reps per set). The number of sets will be gradually increased as tolerance builds.

  • Protein SupplementationDietary supplement

    12-week supply of the commercially-available Premier Protein Clear ® High Protein (20 grams of protein and 90 calories per 16.9 oz. drink). Participants will be asked to consume one drink per day for the 12-week intervention period.

  • MRIDevice

    Participants will be scanned using a 3T MRI scanner and a 16-channel phased array neck coil.

Study groups in NCT05963113
Study groupRoleWhat they receive
Control, then Swallowing Exercises + ProteinExperimentalParticipants randomized to 12 weeks of swallowing exercises with protein supplementation, after completing an initial 12-week period of "usual activity."
Receives: Behavioral: Pharyngeal Swallowing Exercises; Dietary Supplement: Protein Supplementation; Device: MRI
Control, then Swallowing ExercisesActive comparatorParticipants randomized to 12 weeks of swallowing exercises without protein supplementation, after completing an initial 12-week period of "usual activity."
Receives: Behavioral: Pharyngeal Swallowing Exercises; Device: MRI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Thickness of the Superior Pharyngeal Constrictor Muscle

    Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the superior pharyngeal constrictor muscle.

    Measured: Baseline, Week 13

  2. Change in Thickness of the Superior Pharyngeal Constrictor Muscle

    Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the superior pharyngeal constrictor muscle.

    Measured: Baseline, Week 28

  3. Change in Thickness of the Middle Pharyngeal Constrictor Muscle

    Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the middle pharyngeal constrictor muscle.

    Measured: Baseline, Week 13

  4. Change in Thickness of the Middle Pharyngeal Constrictor Muscle

    Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the middle pharyngeal constrictor muscle.

    Measured: Baseline, Week 28

  5. Change in Thickness of the Inferior Pharyngeal Constrictor Muscle

    Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the inferior pharyngeal constrictor muscle.

    Measured: Baseline, Week 13

  6. Change in Thickness of the Inferior Pharyngeal Constrictor Muscle

    Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the inferior pharyngeal constrictor muscle.

    Measured: Baseline, Week 28

  7. Change in Maximum Pharyngeal Constriction During Swallowing

    Maximum pharyngeal constriction area (normalized to spine length) will be captured at the height of the swallow on videofluoroscopy.

    Measured: Baseline, Week 13

  8. Change in Maximum Pharyngeal Constriction During Swallowing

    Maximum pharyngeal constriction area (normalized to spine length) will be captured at the height of the swallow on videofluoroscopy.

    Measured: Baseline, Week 28

Secondary outcomes (6)
  1. Change in Short Physical Performance Battery (SPPB) Scores

    The SPPB comprises a gait speed test, a chair stand test, and three balance tests. The gait speed test score ranges from 0 (worst outcome) to 4 (best outcome); the chair stand test score ranges from 0 (worst outcome) to 4 (best outcome); the side-by-side stand test score ranges from 1 (best outcome) to 0 (worst outcome); the semi-tandem stand test score ranges from 1 (best outcome) to 0 (worst outcome); and the tandem stand test scores range from 2 (best outcome) to 0 (worst outcome).

    The total SPPB score is the sum of the test scores and ranges from 0-12, with lower scores indicating greater disability.

    Measured: Baseline, Week 13

  2. Change in Short Physical Performance Battery (SPPB) Scores

    The SPPB comprises a gait speed test, a chair stand test, and three balance tests. The gait speed test score ranges from 0 (worst outcome) to 4 (best outcome); the chair stand test score ranges from 0 (worst outcome) to 4 (best outcome); the side-by-side stand test score ranges from 1 (best outcome) to 0 (worst outcome); the semi-tandem stand test score ranges from 1 (best outcome) to 0 (worst outcome); and the tandem stand test scores range from 2 (best outcome) to 0 (worst outcome).

    The total SPPB score is the sum of the test scores and ranges from 0-12, with lower scores indicating greater disability.

    Measured: Baseline, Week 28

  3. Change in Fat-Free Muscle Index

    Fat-free muscle index measured via bioelectrical impedance analysis using the InBody 570 multi-frequency analyzer.

    Measured: Baseline, Week 13

  4. Change in Fat-Free Muscle Index

    Fat-free muscle index measured via bioelectrical impedance analysis using the InBody 570 multi-frequency analyzer.

    Measured: Baseline, Week 28

  5. Change in Pre-Albumin Levels

    Levels of pre-albumin, a marked of undernutrition, will be measured using patient blood samples.

    Measured: Baseline, Week 13

  6. Change in Pre-Albumin Levels

    Levels of pre-albumin, a marked of undernutrition, will be measured using patient blood samples.

    Measured: Baseline, Week 28

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2023
  2. Study start22 May 2024
  3. Primary completion31 Aug 2028 (estimated)
  4. Study completion31 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05963113
Sponsor's protocol ID
23-00293
Acronym
PE(PP)
Status last verified
Jun 2026
First submitted
19 Jul 2023
Last updated
3 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The de-identified participant data from the final research dataset used in the published manuscript will be shared upon reasonable request beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research provided the investigator who proposes to use the data executes a data use agreement with NYU Langone Health. Requests may be directed to: smm16@nyu.edu. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.

Questions about this trial

What is this clinical trial studying?

A study testing Pharyngeal Swallowing Exercises, Protein Supplementation and MRI in people with Pre-Frail Older Adults, run by NYU Langone Health at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sonja Molfenter (212-992-7694, Smm16@nyu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Thickness of the Superior Pharyngeal Constrictor Muscle (time frame: Baseline, Week 13). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in